Retrosynthetic analysis

Iktos opens a subsidiary in Japan and entrusts its management to Hideyoshi Fuji

Retrieved on: 
Wednesday, February 14, 2024
Molecule, Urology, Pharmacy, Doctor of Philosophy, AI, Yann, Saas, Generative, Drug design, Drug discovery, RIKEN, Kissei, Retrosynthetic analysis, Software as a service, Astellas Pharma, Artificial intelligence, Computational chemistry, Toyotomi Hideyoshi, Ono Pharmaceutical, Pharmaceutical industry

Paris (France) and Tokyo (Japan), February 14, 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, announces the opening of Iktos K.K., its new subsidiary in Japan.

Key Points: 
  • Paris (France) and Tokyo (Japan), February 14, 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, announces the opening of Iktos K.K., its new subsidiary in Japan.
  • Hideyoshi Fuji has been appointed Representative Director of Iktos K.K., and Vice-President, Japan Business Development and Operations.
  • Hideyoshi, 42, spent 13 years at Astellas Pharma Inc. (2009-2021) as an expert in computational chemistry and chemoinformatics.
  • After his career with Astellas Pharma, Hideyoshi became an entrepreneur in 2022 and supported business development and marketing efforts in Japan for overseas software companies.

Iktos Announce Collaboration with UCB in AI for Retrosynthesis

Retrieved on: 
Tuesday, May 25, 2021
Software, Biotechnology, Pharmaceutical, Health, Data management, Technology, Other Technology, Other Health, Software, Business models, Software distribution, Chemical reaction engineering, Chemical synthesis, Organic chemistry, Retrosynthetic analysis, Software as a service, Computing

Iktos has developed AI based retrosynthesis analysis and planning tool Spaya by harnessing the power of data-driven retrosynthesis algorithm for systematic exploration and prioritisation of synthetic routes for a desired compound in minutes.

Key Points: 
  • Iktos has developed AI based retrosynthesis analysis and planning tool Spaya by harnessing the power of data-driven retrosynthesis algorithm for systematic exploration and prioritisation of synthetic routes for a desired compound in minutes.
  • We are thrilled to initiate a new software licensing agreement with UCB, commented Yann Gaston-Math, President and CEO of Iktos.
  • This new collaboration agreement is another testimony of the leadership position that Iktos has developed in the field of AI for chemistry and drug design.
  • Iktos generative AI SaaS software, Makya, has been deployed to several customers, and Spaya, Iktos retro-synthesis AI SaaS platform, which has been accessible on the Web since March 2020, is now on the commercialization path.

Elsevier and Pending.AI collaborate on AI-driven chemistry retrosynthesis tool

Retrieved on: 
Tuesday, September 15, 2020
Branches of science, Chemistry, Physical sciences, Chemical databases, Business intelligence, Reaxys, Organic chemistry, Formal sciences, Analytics, RELX, Retrosynthetic analysis

The Reaxys-PAI Predictive Retrosynthesis solution uses a model that incorporates deep neural networks trained on Reaxys data.

Key Points: 
  • The Reaxys-PAI Predictive Retrosynthesis solution uses a model that incorporates deep neural networks trained on Reaxys data.
  • The Reaxys-PAI Predictive Retrosynthesis tool will complement the knowledge of scientists and teams and help them to rapidly make more informed decisions."
  • Reaxys-PAI Predictive Retrosynthesis can be further augmented by training on proprietary chemistry reaction data, including a customer's own reaction dataset and building block library.
  • Elsevier is part of RELX Group , a global provider of information and analytics for professionals and business customers across industries.

Elsevier and Pending.AI collaborate on AI-driven chemistry retrosynthesis tool

Retrieved on: 
Tuesday, September 15, 2020
Branches of science, Chemistry, Physical sciences, Chemical databases, Business intelligence, Reaxys, Organic chemistry, Formal sciences, Analytics, RELX, Retrosynthetic analysis

The Reaxys-PAI Predictive Retrosynthesis solution uses a model that incorporates deep neural networks trained on Reaxys data.

Key Points: 
  • The Reaxys-PAI Predictive Retrosynthesis solution uses a model that incorporates deep neural networks trained on Reaxys data.
  • The Reaxys-PAI Predictive Retrosynthesis tool will complement the knowledge of scientists and teams and help them to rapidly make more informed decisions."
  • Reaxys-PAI Predictive Retrosynthesis can be further augmented by training on proprietary chemistry reaction data, including a customer's own reaction dataset and building block library.
  • Elsevier is part of RELX Group , a global provider of information and analytics for professionals and business customers across industries.

CAS Drives Increase in R&D Productivity with Launch of Breakthrough Retrosynthesis Planner in SciFinder-n

Retrieved on: 
Monday, July 1, 2019
Physical sciences, Chemistry, Natural sciences, Production economics, American Chemical Society, Chemical Abstracts Service, Chemical substance, Retrosynthetic analysis, Productivity, Agrochemical

The Retrosynthesis Planner in SciFindern assists chemists with the synthesis portion of this process.

Key Points: 
  • The Retrosynthesis Planner in SciFindern assists chemists with the synthesis portion of this process.
  • Researchers are confirming this new functionality accelerates research, improves productivity and will help them get new products such as pharmaceuticals, agrichemicals and performance chemicals to market faster.
  • CAS developed this new experimental retrosynthesis capability, in part, with Wiley's award-winning ChemPlanner technology.
  • SciFindern , the newest and most advanced solution in the SciFinder family, allows researchers to eliminate productivity bottlenecks and accelerate their innovations to market.

CAS Drives Increase in R&D Productivity with Launch of Breakthrough Retrosynthesis Planner in SciFinder-n

Retrieved on: 
Monday, July 1, 2019
Physical sciences, Chemistry, Natural sciences, Production economics, American Chemical Society, Chemical Abstracts Service, Chemical substance, Retrosynthetic analysis, Productivity, Agrochemical

The Retrosynthesis Planner in SciFindern assists chemists with the synthesis portion of this process.

Key Points: 
  • The Retrosynthesis Planner in SciFindern assists chemists with the synthesis portion of this process.
  • Researchers are confirming this new functionality accelerates research, improves productivity and will help them get new products such as pharmaceuticals, agrichemicals and performance chemicals to market faster.
  • CAS developed this new experimental retrosynthesis capability, in part, with Wiley's award-winning ChemPlanner technology.
  • SciFindern , the newest and most advanced solution in the SciFinder family, allows researchers to eliminate productivity bottlenecks and accelerate their innovations to market.